Recent Development in Thrombin Receptor Antagonist as Novel Antithrombotic Agent

Open Journal of Medicinal Chemistry
doi 10.4236/ojmc.2012.24014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Metabolism-Based Identification of a Potent Thrombin Receptor Antagonist

English

A Thrombin Receptor - Derived Imaging Agent Detects Subclinical Arthritis in Mice

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Antithrombotic Effects of a Platelet Fibrinogen Receptor Antagonist in a Canine Model of Carotid Artery Thrombosis

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1992English

Prevention of the Hypercontractile Response to Thrombin by Proteinase-Activated Receptor-1 Antagonist in Subarachnoid Hemorrhage

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy

PLoS ONE
Multidisciplinary
2015English

Plasma Membrane Calcium ATPases as Novel Candidates for Therapeutic Agent Development

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2013English

Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Antithrombotic Effects of Thrombin-Induced Activation of Endogenous Protein C in Primates.

Journal of Clinical Investigation
Medicine
1993English

The Sphingosine 1-Phosphate Receptor Modulator Fingolimod as a Therapeutic Agent: Recent Findings and New Perspectives

Pharmacology and Therapeutics
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy